본문바로가기
Language
Q
U
I
C
K

Global Innovative Partner of Vaccine and Biotech SK bioscience

From Prevention To Cure
mouse scroll icon SCROLL DOWN

What’s New

  • SK bioscience News SK bioscience and GSK’s Adjuvanted ...

    Recombinant protein-based ‘GBP510’ with GSK pandemic adjuvant demonstrates superior neutralising tit...

    More
  • News SK bioscience Reports Positive...

    For 4,037 adults over 18 years of age, GBP510(AS03...

    More
  • News SK bioscience Initiates Clinic...

    SK began developing an innovative technology to pr...

    More
  • News SK bioscience Submits Post App...

    SK submitted a post-approval change application fo...

    More
  • News SK bioscience Submits Rolling ...

    Efficacy similar to adults 18 years and older with...

    More

Investor Relations

0 PRESENT PRICE (WON)

0WON

0.00%

Our Products

  • SKY Cellflu prefilled syringe
  • SKY Cellflu Quadrivalent prefilled syringe
  • SKY Zoster Inj.
  • SKY Varicella Inj.
PRODUCTS SKY Cellflu prefilled syringe

The first flu vaccine developed by using the cell-culturing method in Korea. It can provide a large amount of vaccine in a short period of time, as this method can produce a large amount of specific cells which are necessary for cultivating viruses in advance. Furthermore, people with egg allergies can be inoculated at the same time.

SKY Cellflu prefilled syringe image